Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012
Cash Flows from Operating Activities:
Net loss	$ (957,896)		$ (3,041,730)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	37,576		26,416
Value of stock options granted	131,866		1,931,325
Changes in operating assets and liabilities:
Prepaid expenses	(144,343)		28,724
Inventory	45,548		(91,547)
Customer deposits	(4,554)		10,000
Accounts payable (includes related parties)	(15,280)		59,931
Accrued expenses (includes related parties)	(29,483)		26,611
Net Cash Used in Operating Activities	(936,566)		(1,050,270)
Cash Flows from Investing Activities:
Purchase of trademark and patents	(36,551)		(89,118)
Purchase of property and equipment	(7,540)		(3,148)
Net Cash Used in Investing Activities	(44,091)		(92,266)
Cash Flows from Financing Activities:
Principal payments on notes payable	(51,189)		(26,449)
Issuance of common stock for cash	1,160,250		1,284,935
Net Cash Provided by Financing Activities	1,109,061		1,258,486
Effect of Foreign Currency Exchange Rates	(86)		(1,589)
Net increase in cash	128,318		114,361
Cash as of beginning of the period	12,456	[1]	129,759
Cash as of end of the period	140,774		244,120
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash Paid for Interest	697		702
NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 62,987		$ 54,678

[1] The condensed consolidated balance sheet as of December 31, 2012 has been prepared using information from the audited balance sheet as of that date.